Skip to Content
Merck
CN

Smad3 mutant mice develop colon cancer with overexpression of COX-2.

Oncology letters (2017-04-30)
Yu-Ping Zhu, Zhuo Liu, Zhi-Xuan Fu, De-Chuan Li
ABSTRACT

Colon cancer is the second most common cause of cancer-associated mortality in human populations. The aim of the present study was to identify the role of cyclooxygenase-2 (COX-2) in Smad3 mutant mice, which are known to develop colon cancer. Homozygous Smad3 (-/-) mutant mice were generated from inbred and hybrid Smad3 mouse strains by intercrossing the appropriate heterozygotes. Immunohistochemistry with COX-2 antibody was performed throughout this experiment and the data was validated and cross-checked with reverse transcription-polymerase chain reaction (RT-PCR). Homozygous mutant Smad3 mice were generated and the overexpression pattern of COX-2 was identified by immunohistochemistry and validated with RT-PCR. The results of the present study demonstrated a link between the Smad3 mutant mice, colon cancer and COX-2. In addition, the overexpression pattern of COX-2 in Smad3 mutant mice that develop colon cancer was identified.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-COX2/PTGS2 antibody produced in goat, affinity isolated antibody, buffered aqueous solution